These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28106934)

  • 21. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder.
    Vilar-Ribó L; Sánchez-Mora C; Rovira P; Richarte V; Corrales M; Fadeuilhe C; Arribas L; Casas M; Ramos-Quiroga JA; Ribasés M; Soler Artigas M
    Am J Med Genet B Neuropsychiatr Genet; 2021 Apr; 186(3):140-150. PubMed ID: 33244849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC.
    De Alwis D; Lynskey MT; Reiersen AM; Agrawal A
    Addict Behav; 2014 Aug; 39(8):1278-85. PubMed ID: 24821471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and correlates of ADHD in individuals with substance use disorder in Nigeria.
    Umar MU; Salihu AS; Owolabi SD
    Atten Defic Hyperact Disord; 2017 Sep; 9(3):189-198. PubMed ID: 28097536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of substance use disorder on ADHD and its treatment.
    Wilens TE; Upadhyaya HP
    J Clin Psychiatry; 2007 Aug; 68(8):e20. PubMed ID: 17876905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives.
    Skoglund C; Chen Q; Franck J; Lichtenstein P; Larsson H
    Biol Psychiatry; 2015 May; 77(10):880-6. PubMed ID: 25457227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
    Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
    Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.
    Kronenberg LM; Slager-Visscher K; Goossens PJ; van den Brink W; van Achterberg T
    BMC Psychiatry; 2014 Sep; 14():264. PubMed ID: 25234344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reward Processing in Drug-Naive Youth with Various Levels of Risk for Substance Use Disorders: A Pilot Study.
    Ivanov I; Schulz K; Li X; Newcorn J
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(7):516-525. PubMed ID: 31180232
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) among Substance Use Disorder (SUD) Populations: Meta-Analysis.
    Rohner H; Gaspar N; Philipsen A; Schulze M
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal Structural Neuroimaging Markers of Brain Development and ADHD Symptoms.
    Ball G; Malpas CB; Genc S; Efron D; Sciberras E; Anderson V; Nicholson JM; Silk TJ
    Am J Psychiatry; 2019 Jan; 176(1):57-66. PubMed ID: 30220220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.
    van de Glind G; Konstenius M; Koeter MWJ; van Emmerik-van Oortmerssen K; Carpentier PJ; Kaye S; Degenhardt L; Skutle A; Franck J; Bu ET; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitány-Fövény M; Fatséas M; Auriacombe M; Schillinger A; Møller M; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Schoevers RA; Wallhed S; Barta C; Alleman P; ; Levin FR; van den Brink W
    Drug Alcohol Depend; 2014 Jan; 134():158-166. PubMed ID: 24156882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice.
    Clure C; Brady KT; Saladin ME; Johnson D; Waid R; Rittenbury M
    Am J Drug Alcohol Abuse; 1999 Aug; 25(3):441-8. PubMed ID: 10473007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of substance misuse and current family history of substance use disorder on brain structure in adolescents and young adults with attention-deficit/hyperactivity disorder.
    Novi M; Paraskevopoulou M; Van Rooij D; Schene AH; Buitelaar JK; Schellekens AFA
    Drug Alcohol Depend; 2021 Nov; 228():109032. PubMed ID: 34555690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD).
    Perugi G; Pallucchini A; Rizzato S; De Rossi P; Sani G; Maremmani AG; Pinzone V; Maremmani I
    Expert Opin Pharmacother; 2019 Feb; 20(3):343-355. PubMed ID: 30513231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention-Deficit/Hyperactivity Disorder Symptoms, Sensation-Seeking, and Sensory Modulation Dysfunction in Substance Use Disorder: A Cross Sectional Two-Group Comparative Study.
    Assayag N; Berger I; Parush S; Mell H; Bar-Shalita T
    Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.